Treatment of periorbital edema with human corticotropin-releasing factor after blepharoplasty

Journal of the American College of Surgeons

Volumn 182, Issue 3, 1996, Pages 226-232

  Schendel, Stephen A ^a,b   Stephanides, Michael ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; PLACEBO;

ADULT; ARTICLE; BLOOD VESSEL PERMEABILITY; CELL MEMBRANE PERMEABILITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ENDOCRINE FUNCTION; ENDOTHELIUM CELL; EYELID EDEMA; EYELID RECONSTRUCTION; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

CORTICOTROPIN-RELEASING HORMONE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; EDEMA; EYELIDS; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; ORBITAL DISEASES; POSTOPERATIVE COMPLICATIONS; PREMEDICATION; PROSPECTIVE STUDIES;

EID: 0029869292     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Schurmeyer, T. H., Avgerinos, P. C., Gold, P. W., and others. Human corticotropin-releasing factor in man: pharmacokinetic properties and dose-response of plasma adrenocorticotropin and cortisol secretion. J. Clin. Endocrinol Metab., 1984, 59: 1103-1108.
2. Vale, W., Spiess, J., Rivier, C., and Rivier J. Characterization of 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and β-endorphin. Science, 1981, 213: 1394-1397.
3. Dunn, C. W. Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress response? Brain Res., 1990, Bull. 15: 71-100.
4. Campbell, E. A., Linton, E. A., Wolfe, C. D. A., and others. Plasma corticotropin-releasing hormone concentrations during pregnancy and parturition. J. Clin. Endocrinol. Metab., 1987, 64: 1054-1059.
5. Kiang, J. G., Poree, L., and Wei, E. T. Anti-inflammatory activity of corticotropin-releasing factor II. Mechanisms of action. Proc. West. Pharmacol. Soc., 1987, 30: 63-65.
6. Gao, G. C., Dashwood, M. R., and Wei, E. T. Corticotropin-releasing factor inhibition of substance P-induced vascular leakage in rats: possible sites of action. Peptides, 1991, 12: 639-644.
7. Serda, S. M., and Wei, E. T. Epinephrine-induced pulmonary edema in rats is inhibited by corticotropin-releasing factor. Pharmacol. Res., 1992, 26: 85-91.
8. Wei, E. T., and Gao, G. C. Corticotropin-releasing factor (CRF): an inhibitor of vascular leakage in skeletal muscle and brain cortex after injury. Regul. Pept., 1991, 33: 93-104.
9. Wen, H. L., Kwok, J. C. K., and Datta, N. The use of corticotropin-releasing factor (CRF) for the treatment of post-operative cerebral edema. Chin. Med. J., 1991, 104: 557-561.
10. Blasberg, R. G., and Tjuvaiev, J. Submitted for publication, 1994.
11. Wei, E. T., Gao, G. C., and Thomas, H. A. Peripheral anti-inflammatory actions of CRF. Ciba Foundation Symposium No. 172 on Corticotropin Releasing Factor. Edited bv D. J. Chadwick, J. Marsh, and K. Ackrill. Chichester: John Wiley & Sons. 1993.
12. Wei, E. T., and Thomas, H. A. Anti-inflammatory peptide agonists. Annual Review of Pharmacology and Toxicology. Edited by A. Cho, T. S. Blasche, H. H. Loh, J. L. Wei. Vol. XXXIII, pp. 258-268. Palo Alto, CA: Annual Reviews, 1993.
13. Schulte, H. M., Chrousos, G. P., Avgerino, P., and others. The corticotropin-releasing hormone stimulation test: a possible aid in the evaluation of patients with adrenal insufficiency. J. Clin. Endocrinol. Metab., 1984, 58: 1064-1067.
14. Avgereinos, P. C., Schurmeyer, T. H., and others. Pulsatile administration of human corticotropin-releasing hormone in patients with secondary adrenal insufficiency: restoration of the normal cortisol secretory pattern. J. Clin. Endocrinol. Metab., 1986, 62: 816-821.
15. Nieman, L. K., Cutler, G. B., Oldfield, E. H., and others. The ovine corticotropin-releasing hormone (CRH) stimulation test is superior to the human CRH stimulation test for diagnosis of Cushing's Disease. J. Clin. Endocrinol. Metab., 1989, 69: 165-169.
16. Karalis, K., Sano, H., Redwine, J., and others. Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo. Science, 1991, 254: 421-423.
17. Hermus, A., Raemaekers, J. M. M., Pieters, G. F. F. M., and others. Serious reactions to corticotropin-releasing factor. Lancet. 1983, 2: 776.
18. Schulte, H. M., Chrousos, G. P., Gold, P. W., and others. Continuous administration of synthetic ovine corticotropin-releasing factor in man. J. Clin. Invest., 1985, 75: 1781-1785.
19. Desir, D. E., VanCouter, E., Beyloos, M., and others. Prolonged pulsatile administration of ovine corticotropin-releasing hormone in normal man. J. Clin. Endocrinol. Metab., 1986, 63: 1292-1298.
20. Oldfield, E. H., Schulte, H. M., Chrousos, G. P., and others. Corticotropin-releasing hormone (CRH) stimulation in Nelson's Syndrome: response of adrenocorticotropin secretion to pulse injection and continuous infusion of corticotropin-releasing hormone. J. Clin. Endocrinol. Metab., 1986, 62: 1020-1026.
21. Ross, J. L., Schulte, H. M., Gallucci, W. T., and others. Ovine corticotropin-releasing hormone stimulation test in normal children. J. Clin. Endocrinol. Metab., 1986, 62: 390-392.
22. Opperman, D., Huber, I., Nink, M., and others. Human corticotropin-releasing hormone in man: dose-response of minute ventilation and end-tidal partial pressures of carbon dioxide and oxygen. J. Clin. Endocrinol. Metab., 1987, 64: 292-296.
23. Schrell, U., Fahlbusch, R., Buchfelder, M., and others. Corticotropin-reteasing hormone stimulation test before and after transsphenoidal selective microadenomectomy in 30 patients with Cushing's Disease. J. Clin. Metab., 1987, 64: 1150-1158.
24. Suda, T., Iwashita, M., Ushiyama, T., and others. Responses to corticotropin-releasing hormone and its bound and free forms in pregnant women and nonpregnant women. J. Clin. Endocrinol. Metab., 1989, 69: 38-42.
25. Demitrack, M. A., Dale, J. K., Straus, S. E., and others. Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome. J. Clin. Endocrinol. Metab., 1991, 73: 1224-1234.
26. Dahl, R. E., Siegel, S. F., Williamson, P. A., and others. Corticotropin-releasing hormone stimulation test and nocturnal cortisol levels in normal children. Pediatr. Res., 1992, 32: 64-68.
27. Nink, M., Beyer, J., Krause, U., and others. Effects of corticotropin-releasing hormone on the postoperative course of elderly patients under long-term artificial respiration. Acta Endocrinol., 1992, 127: 200-204.
28. Nink, M., Krause, U., Lehnert, H., and Beyer, J. Safety and side effects of human and ovine corticotropin-releasing hormone administration in man. Klin. Wochenschrift, 1991, 69: 185-195.